Trecento Diagnostics has developed DNA extraction techniques from urine, reducing the need for needles and blood tests in companion animal healthcare. With patent-pending collection device & molecular testing system complete, they’re ready to launch and introduce non-invasive testing in the vet practice.
Vets currently use both urine & blood analysis to help determine canine health. Collecting urine samples can be difficult & also invasive if needle into bladder procedures (Cystocentesis) are required, taking blood samples can also be difficult & stressful for all involved, & vets/owners can wait 48hrs for costly external lab results.
We aim to change this having developed a patent-pending collection device, HygieCatch®, making it easy to collect canine urine. Crucially, we’ve developed a technique for onsite extraction of DNA from urine paired with software that translates the test results via our desktop molecular testing system. This means, once the sample has been prepared, we can deliver results in the vet’s office in 40 min.
Our three-fold revenue streams will come from Hygecatch®, the Molecular testing machine and our range of tests.
We’ve achieved a lot; invented, developed, tested & patented HygieCatch. Developed unique DNA extraction techniques, produced ready for market T300 molecular system and software & have plans in place to extend the range of tests including Lyme disease.
We are in early-stage discussions with UK vet practices and identified partners in the US and UAE, & the company is now looking to raise capital to support the commercialisation of HygieCatch & the technology, alongside further development of new tests, looking to expand offering and market share.